Covid: No safety concerns found with Oxford vaccine trial after Brazil death
Oxford University says a review has found no safety concerns after the Brazilian volunteer's death.
Full Article
Covid: No safety concerns found with Oxford vaccine trial after Brazil death
BBC News
0 shares
2 views
You might like
Related news coverage
NA Proactive news snapshot: Medexus Pharmaceuticals, Next Green Wave, Humanigen, Canada Silver Cobalt Works, American Resources UPDATE...
Proactive Investors
Medexus Pharmaceuticals Inc (CVE:MDP) (OTCQX:MEDXF) revealed that it has struck an agreement with Geneva, Switzerland-based..
-
COVID-19 vaccine: Infections reported among Sputnik V trial volunteers
Mid-Day
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
-
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
-
AstraZeneca resuming US testing of COVID-19 vaccine
SeattlePI.com
Advertisement
More coverage
AstraZeneca Covid-19 Vaccine Trial In Brazil To Continue Despite Volunteer's Death
RTTNews
A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University,..
-
Oxford vaccine volunteer dies in Brazil, marking first death reported during a coronavirus trial
SBS
-
Oxford vaccine volunteer dies in Brazil, marking first death reported during a coronavirus vaccine trial
SBS
-
Oxford vaccine volunteer dies in Brazil, marking first death reported in a coronavirus vaccine trial
SBS
-
AstraZeneca/Oxford Coronavirus Vaccine Trial in Brazil to Continue Following Death of Volunteer
Upworthy